DeNovix Inc. announces the award of Japanese Patent No. 6579475 covering their innovation in the field of cell counting.
The presence of debris, non-nucleated cells and highly variable cell numbers can make counting primary cells challenging. Peripheral Blood Mononuclear Cells (PBMCs) are a common primary cell source where accurate enumeration is essential. This technical note outlines the best practices for counting PBMCs using the CellDrop Automated Cell Counter.
DeNovix offers a range of brightfield and fluorescence beads as an alternative to biological samples for cell counter training and qualification purposes.
US Senator Chris Coons was welcomed to DeNovix Inc. to visit the expanded facilities and view the recently patented CellDrop™.
In this post, DeNovix explores primary cell counting using AO/PI with a focus on peripheral blood mononuclear cells (PBMCs).
Despite the variety of cell counters available, they can typically be divided into one of two sub-groups: manual and automated cell counters.
DeNovix Inc. announces the award of US Patent 10,302,568 for their innovation in the field of cell counting.
Various methods of cell counting exist for quantifying the total number of cells in solution and calculating sample viability.
DeNovix announces the launch of the CellDrop Automated Cell Counter, the first instrument to remove the need for cell counting slides.
